参考文献/References:
［１］Leong ASY．Epidemiology，risk factors，etiology，premalignant lesions and carcinogenesis［M］．∥Leong ASY，Liew CT，Lau JWY，et al，Hepatocellular carcinoma：contemporary diagnosis，investigation and management．London：Arnold，１９９９，１-１７．
［２］Pauser S，Wanger S，Lippmann M，et al．Evaluation of efficient chemoembolization mixtures by magnetic resonance imaging therapy monitoring：An experimental study on the VX２tumor in the rabbit liver［J］．Cancer Res，１９９６，５６：１８６３-１８６７
［３］郭卫平，刘燕，王执民，等．兔肝VX２移植癌改良模型的建立［J］．中国医学影像技术，２００２，１８：３９７-３９９．
［４］卢勤，滕皋军．p５３基因治疗肿瘤的研究进展［J］．中华放射学杂志，２０００，３４：６５９-６６１．
［５］Habib NA，Hodgson HJ，Lemoine N，et al．A phase I／II study of hepatic artery infusion with wtp５３-CMV-Ad in metastatic malignant liver tumours［J］．Hum Gene Ther，１９９９，１０：２０１９-２０３４．
［６］Bookstein R，Demers W，Gregory R，et al．P５３gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer［J］．Sem in oncol，１９９６，２３：６６-７７．
［７］Hirao K，Sugita T，Kubo T，et al．Targeted gene delivery to human osteosarcoma cells with magnetic cationic liposomes under a magnetic field［J］．Int J Oncol，２００３，２２：１０６５-１０７１．
［８］Gautam A，Waldrep JC，Densmore CL，et al．Growth inhibition of established B１６-F１０lung metastases by sequential aerosol delivery of p５３gene and９-nitrocamptothecin［J］．Gene Ther，２００２，９：３５３-３５７
［９］Riva CM．Restoration of wild-type p５３activity enhances the sen-sitivity of pleural metastasis to cisplatin through an apoptotic mechanism［J］．Anticancer Res，２０００，２０：４４６３-４４７１．
［１０］Pastorino F，Brignole C，Marimpietri D，et al．Targeted delivery of oncogene-selective antisense oligonucleotides in neuroecto-dermal tumors：therapeutic implications［J］．Ann N Y Acad Sci，２００４，１０２８：９０-１０３．
［１１］Chipuk JE，Kuwana T，Bouchier-Hayes L，et al．Direct activa-tion of Bax by p５３mediates mitochondrial membrane permeabili-zation and apoptosis［J］．Science，２００４，３０３：１０１０-１０１４．
［１２］McPake CR，Shetty S，Kitchingman GR，et al．Wild-type p５３induction mediated by replication-deficient adenoviral vectors［J］．Cancer Res，１９９９，５９：４２４７-４２５１．
［１３］Bookstein R，Demers W，Gregory R，et al．p５３gene therapy in vivo of hepatocellular and liver metastatic colorectal cancer［J］．Semin Onclo，１９９６，２３：６６-７７．
［１４］Mohr L，Yoon SK，Eastman SJ，et al．Cationic liposome-me-diated gene delivery to the liver and to hepatocellular carcinomas in mice［J］．Hum Gene Ther，２００１，１２：７９９-８０９．
［１５］Gharwan H，Wightman L，Kircheis R，et al．Nonviral gene transfer into fetal mouse livers（a comparison between the cationic polymer PEI and naked DNA）［J］．Gene Ther，２００３，１０：８１０-８１７．
［１６］Ogris M，Wagner E．Tumor-targeted gene transfer with DNA pol-yplexes［J］．Somat Cell Mol Genet，２００２，２７：８５-９５．
相似文献/References:
[1]程永德,陈雪萍,高发年,等.甲氨喋呤脂质体动脉灌注治疗肝癌的初步观察[J].介入放射学杂志,1993,(01):44.
[2]陈世晞,陈骏,徐卫东,等.动脉灌注p５３基因治疗晚期肝癌的初步临床应用[J].介入放射学杂志,2007,(02):127.
CHEN Shi-xi,CHEN Jun,XU Wei-dong,et al.A preliminary clinical study on p５３gene in the therapy of advanced hepatocellular carcinoma[J].journal interventional radiology,2007,(02):127.
[3]卢勤,牛焕章,朱光宇,等.经导管动脉输送转铁蛋白增强p５３基因转染效率的研究[J].介入放射学杂志,2007,(02):99.
LU Qin,NIU Huan-zhang,ZHU Guang-yu,et al.Investigation of transfection efficacy with transcatheter arterial transporting transferrin to enhance p５３gene[J].journal interventional radiology,2007,(02):99.